The Australian medical sector is buzzing with the arrival of retatrutide, a groundbreaking dual GIP and GLP-1 medication showing significant results in clinical trials for addressing obesity. This therapy https://veriea.com/2026/06/10/retatrutide-australia-the-next-generation-in-weight-loss/